Study of DS-8273a With Nivolumab in Unresectable Stage III or Stage IV Melanoma
Clinical trial NCT02983006 · COMPLETED
Trial details
- NCT number
- NCT02983006
- Sponsor
- NYU Langone Health
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-01
- Primary completion
- 2019-12-23
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.